Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Schulte, JH*" or (type exact bookEditor and editor="Schulte, JH*")

Add to list
Modulation of neuroblastoma disease pathogenesis by an extensive network of epigenetically regulated microRNAs

S Das, K Bryan, PG Buckley, O Piskareva, IM Bray, N Foley, J Ryan, J Lynch, L Creevey, J Fay, et al.

(2013) ONCOGENE. 32(24). p.2927-2936
Add to list
MYCN and ALKF1174L are sufficient to drive neuroblastoma development from neural crest progenitor cells

JH Schulte, S Lindner, A Bohrer, J Maurer, Katleen De Preter (UGent) , Steve Lefever (UGent) , L Heukamp, S Schulte, J Molenaar, R Versteeg, et al.

(2013) ONCOGENE. 32(8). p.1059-1065
Add to list
Oncogenic activation of FOXR1 by 11q23 intrachromosomal deletion-fusions in neuroblastoma

EE Santo, ME Ebus, J Koster, JH Schulte, A Lakeman, P van Sluis, J Vermeulen, D Gisselsson, I Øra, S Lindner, et al.

(2012) ONCOGENE. 31(12). p.1571-1581
Add to list
Exon-level expression analyses identify MYCN and NTRK1 as major determinants of alternative exon usage and robustly predict primary neuroblastoma outcome

A Schramm, B Schowe, K Fielitz, M Heilmann, M Martin, T Marschall, J Köster, Jo Vandesompele (UGent) , Joëlle Vermeulen (UGent) , Katleen De Preter (UGent) , et al.

(2012) BRITISH JOURNAL OF CANCER. 107(8). p.1409-1417
Add to list
Lysine-specific demethylase 1 restricts hematopoietic progenitor proliferation and is essential for terminal differentiation

A Sprüssel, JH Schulte, S Weber, M Necke, K Händschke, T Thor, KW Pajtler, A Schramm, K König, L Diehl, et al.

(2012) LEUKEMIA. 26(9). p.2039-2051
Add to list
MYCN/c-MYC-induced microRNAs repress coding gene networks associated with poor outcome in MYCN/c-MYC-activated tumors

Pieter Mestdagh (UGent) , E Fredlund, Filip Pattyn (UGent) , JH Schulte, D Muth, Joëlle Vermeulen (UGent) , Candy Kumps (UGent) , S Schlierf, Katleen De Preter (UGent) , Nadine Van Roy (UGent) , et al.

(2010) ONCOGENE. 29(9). p.1394-1404
Add to list
Accurate Outcome Prediction in Neuroblastoma across Independent Data Sets Using a Multigene Signature

Katleen De Preter (UGent) , Joëlle Vermeulen (UGent) , B Brors, O Delattre, A Eggert, M Fischer, I Janoueix-Lerosey, C Lavarino, JM Maris, J Mora, et al.

(2010) CLINICAL CANCER RESEARCH. 16(5). p.1532-1541
Add to list
- Conference Paper
- C3
The miR-17-92 gene cluster is amplified and overexpressed in retinoblastoma

E Biewald, Pieter Mestdagh (UGent) , H Stephan, Katleen De Preter (UGent) , T Thor, M Baumann, D Lohmann, A Eggert, Franki Speleman (UGent) , A Schramm, et al.

(2009) KLINISCHE PADIATRIE. 221(3).
Add to list
- Conference Paper
- C3
ALK Mutation Analysis in Patients of the German Neuroblastoma Study

B Brockmeyer, JH Schulte, A Oberthuer, Pieter Mestdagh (UGent) , K Pajtler, J Theissen, H Bachmann, B Hero, Jo Vandesompele (UGent) , F Berthold, et al.

(2009) KLINISCHE PADIATRIE. 221(3). p.195-195
Add to list
- Conference Paper
- C3
Prognostic role and functional analyses of miRNA expression in neuroblastoma

S Schlierf, Pieter Mestdagh (UGent) , T Thor, Katleen De Preter (UGent) , M Baumann, A Eggert, Jo Vandesompele (UGent) , A Schramm and JH Schulte

(2009) KLINISCHE PADIATRIE. 221(3).
Add to list
- Journal Article
- A1
Translating expression profiling into a clinically feasible test to predict neuroblastoma outcome

A SCHRAMM, Jo Vandesompele (UGent) , JH SCHULTE, S DREESMANN, L KADERALI, B BRORS, R EILS, Franki Speleman (UGent) and A EGGERT

(2007) CLINICAL CANCER RESEARCH. 13(5). p.1459-1465

Academic Bibliography

Modulation of neuroblastoma disease pathogenesis by an extensive network of epigenetically regulated microRNAs

MYCN and ALKF1174L are sufficient to drive neuroblastoma development from neural crest progenitor cells

Oncogenic activation of FOXR1 by 11q23 intrachromosomal deletion-fusions in neuroblastoma

Exon-level expression analyses identify MYCN and NTRK1 as major determinants of alternative exon usage and robustly predict primary neuroblastoma outcome

Lysine-specific demethylase 1 restricts hematopoietic progenitor proliferation and is essential for terminal differentiation

MYCN/c-MYC-induced microRNAs repress coding gene networks associated with poor outcome in MYCN/c-MYC-activated tumors

Accurate Outcome Prediction in Neuroblastoma across Independent Data Sets Using a Multigene Signature

The miR-17-92 gene cluster is amplified and overexpressed in retinoblastoma

ALK Mutation Analysis in Patients of the German Neuroblastoma Study

Prognostic role and functional analyses of miRNA expression in neuroblastoma

Translating expression profiling into a clinically feasible test to predict neuroblastoma outcome

Contents

Support

Contact